Critical Challenges in
Cardiovascular Disease

Linking Science to Therapeutic Advances in The African American Patient Population
Lake Buena Vista, FL

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Intended Audience:

This webcast is designed for physicians, medical researchers, physician assistants, nurses and nurse practitioners, pharmacists, and all healthcare providers managing patients with heart disease and hypertension.

Registration:

Enrollment for this webcast is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from Novartis Pharmaceuticals.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Shawna D. Nesbitt, MD, MS
Grant/Research Support: Pfizer
Consultant: Novartis, BMS
Speakers Bureau: Boerhinger Ingelheim, Novartis, AstraZeneca

Ken Jamerson, MD
Research Support: NIH, NHLBI, NIH, NIDDK, Novartis, King Pharmaceuticals
Consultant: MSD, Pfizer, Novartis, Speedel

Jackson T. Wright, Jr., MD, PhD, FACP
Research Support: Glaxo Smith Kline, Novartis
Consultant: Novartis, MSD, Sanofi, BMS, Pfizer, NIH
Honoraria: Novartis, Biovail, Sanofi, Pfizer

Program Faculty:

Program Chairwoman
Shawna D. Nesbitt, MD, MS
Associate Professor
Department of Internal Medicine
Division of Hypertension
University of Southwestern Texas
Medical School
Dallas, Texas

Ken Jamerson, MD
Professor of Medicine, Pediatrics, Pharmacology and Physiology
Professor of Medicine
Cardiovascular Medicine
University of Michigan Health
System
Ann Arbor, Michigan

Jackson T. Wright, Jr., MD, PhD, FACP
Professor of Medicine
Program Director, General Clinical
Research Center
Case Western Reserve University
Director, Clinical Hypertension Program
University Hospitals of Cleveland
Chief, Case Western Reserve
University Hypertension Section
(Louis Stokes VAMC)
Cleveland, Ohio

Educational Objectives:

• Recognize markers of target organ damage and learn which antihypertensive agents are useful for preventing end organ complications such as CV disease and diabetic renal disease.
• Manage hypertension as a systematic disease, with multiple manifestations, and associations, including metabolic syndrome and associated risk factors.
• Address complications linked to healthcare disparities observed in specific patient populations, and the importance of providing access, treatment, and monitoring of patients with multiple risk CV risk factors.
• Manage African American patients with features of the metabolic syndrome, and its implications for multiple risk factor management

Disclaimer:

Copyright © 2007 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this WebCAST reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this WebCAST is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this WebCAST is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This WebCAST is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This WebCAST is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations

Copyright (c) 2007 All rights reserved